Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription - PubMed (original) (raw)

Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription

D Braaten et al. J Virol. 1996 Jun.

Abstract

Cyclophilin A (CyPA) is incorporated into human immunodeficiency virus type 1 (HIV-1) virions via contact with the Gag polyprotein. Genetic or pharmacologic disruption of CyPA incorporation causes a quantitative reduction in virion infectivity with no discernible effects on virion assembly or on endogenous reverse transcriptase activity. Instead, the reduction of virion-associated CyPA is accompanied by a parallel, quantitative decrease in the initiation of viral DNA synthesis after infection of T cells. The infectivity of CyPA-deficient virions is not restored by pseudotyping with Env of amphotropic murine leukemia virus, demonstrating that CyPA is not required for the HIV-1-Env-CD4 interaction. These results indicate that CyPA is required for an early step in the HIV-1 life cycle following receptor binding and membrane fusion but preceding reverse transcription. CyPA is the first cellular protein other than the cell surface receptor shown to be required for an early event in the life cycle of a retrovirus.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1993 Oct 14;365(6447):666-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8351-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5381-5 - PubMed
    1. J Virol. 1993 Nov;67(11):6542-50 - PubMed
    1. J Virol. 1990 Oct;64(10):5076-92 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources